Metformin potentiates the anticancer activities of gemcitabine and cisplatin against cholangiocarcinoma cells in vitro and in vivo
作者
Zhu, HQ;Ma, JB;Song, X;Gao, HJ;Ma, CQ;Chang, H;Li, HG;Liu, FF;Lu, J;Zhou, X
作者单位
[Zhu, Hua-Qiang; Song, Xie; Gao, Heng-Jun; Ma, Chao-Qun; Chang, Hong; Li, Hong-Guang; Liu, Fang-Feng; Lu, Jun; Zhou, Xu] Shandong Univ, Shandong Prov Hosp, Dept Hepatobiliary Surg, 9677 Jingshi Rd, Jinan 250014, Shandong, Peoples R China.;-;[Ma, Jin-Ben] Shandong Univ, Shandong Prov Hosp, Dept Anesthesiol, Jinan 250014, Shandong, Peoples R China.
摘要
Metformin, an oral biguanide drug used to treat type 2 diabetes, has displayed anticancer activities in several types of cancer cells. The combination of gemcitabine and cisplatin is the standard chemotherapy regimen for cholangiocarcinoma, but its benefit is limited. The present study aimed to investigate whether metformin could enhance the activities of gemcitabine and cisplatin against cholangiocarcinoma, and the underlying mechanisms. Metformin inhibited the proliferation of human cholangiocarcinoma RBE and HCCC-9810 cells and induced cell cycle arrest at the G0/G1 phase by increasing the activation of AMP-activated protein kinase (AMPK) pathways. Metformin upregulated the expression of p21(waf1) and p27(kip1), and downregulated the expression of cyclin D1, a key protein required for cell cycle progression. The combination of gemcitabine and cisplatin inhibited the proliferation and induced the apoptosis of human cholangiocarcinoma cells by inducing the phosphorylation of AMPK, downregulating cyclin D1, and activating caspase-3. Administration of metformin enhanced the efficacy of gemcitabine and cisplatin to suppress the growth of cholangiocarcinoma tumors established in experimental models by inhibiting cell proliferation and inducing cell apoptosis through their effects on AMPK, cyclin D1 and caspase-3. Given that metformin has been used to treat type 2 diabetes patients for over half a century due to its superior safety profile, the results presented here indicate that metformin may be a potent agent for enhancing the efficacy of gemcitabine and cisplatin in the treatment of cholangiocarcinoma.
关键词
ANTIDIABETIC DRUG METFORMIN; HEPATOCELLULAR-CARCINOMA CELLS; INTRAHEPATIC CHOLANGIOCARCINOMA; GASTRIC-CANCER; BREAST-CANCER; STEM-CELLS; OLD DRUG; THERAPY; PATHWAY; PROLIFERATION
基本信息
